Location: Home
  • search
  • go
  • Relate News
  • 3/13/2019NHSA Issues Action Plan for 2019 NRDL Revision
  • 3/13/2019Chongqing Approved to Set Up Destination Port for First-Time Import of...
  • 3/12/2019CDE Publicizes 8+3 More Drug Applications To Be Granted Priority Revie...
  • 3/8/2019China to Open More Vaccine Related Areas to Foreign Companies
  • 3/8/2019Booming Chinese Biotech Confronted by Sudden Investment Drop
  • 3/8/2019Spain's Grifols Acquires Stake in Shanghai RAAS for US$1.9B
  • 3/7/2019CASI Pharma Announces CTA Approval for MARQIBO
  • 3/7/2019Novo Nordisk Launches Innovation Platform INNOVO in China
  • 3/6/2019Ambrx and BeiGene Announce Global R&D Collaboration to Develop...
  • 3/6/2019China Withdraws Preliminary Approval Process at the Provincial Level f...
  • 3/6/2019WuXi STA and Ark Biosciences Sign CMC Development and Manufacturing Ag...
  • 3/5/2019Central Government Report Highlights Pharma-related Major Tasks in 201...
  • 3/5/2019NHSA Issues Complementary Measures for the 4+7 Trial
  • 3/5/2019Novartis Reports Positive Data from Chinese Trial of Cosentyx for Psor...
  • 3/4/2019NHSA Commissioner Reveal Plan to Revise NRDL in 2019 at the Two Sessio...
  • 3/1/2019Recent Executive Moves
  • 3/1/2019IQVIA/McKinsey: Generics Continue to Dominate Chinese Pharma Market
  • 3/1/2019CDE Solicits Comments on eCTD Technical and Validation Guidelines
  • 3/1/2019I-Mab Biopharma and BCT to Collaborate on Arginine Depletion Therapy a...
  • 3/1/2019Novo Nordisk Becomes First to Sign Bilateral APA with China
  • 3/1/2019Financial-related Company News in Brief 02/2019
  • 2/28/2019NHSA Holds Hearing of Pharmaceutical Industry Representatives
  • 2/27/20192019 AmCham China Business Climate Survey: Growth Continues Amid Heigh...
  • 2/27/2019NHSA to Step Up Fraud Crackdown with New Document on BMI Fund Regulati...
  • 2/27/2019NHC Solicits Comments on the Provisions for Clinical Application of Ne...
  • 2/27/2019New IFPMA Code of Practice Tightens Restrictions on Gifts (with Case o...
  • 2/26/2019China Approves Rituxan Copy as the First Biosimilar in China
  • 2/22/2019Novartis Submits NDA of Latest MS Drug Siponimod in China
  • 2/21/2019NHSA and NHC to Introduce Measures Securing Consumption Volume of 4+7 ...
  • 2/21/2019China to Include More Drugs for BMI Reimbursement as It Step Up Caner ...
  • Page:145/357 Total number of articles:10698: [First][<<] [143] [144] [145] [146] [147] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group